The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

WHO has prequalified two Covid-19 rapid antigen tests for the first time, confirming long-term quality and enabling UN ...

The World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for ...

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...

WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...

For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...

SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...